Abilify, the Most-Profitable Drug in America, has been linked to both Gambling Addiction and Sex Addiction. Bristol-Myers Squibb’s top-selling Abilify drug earned the company $6.4 billion in 2013. Doctors prescribe Abilify for the treatment of depression, bipolar disorder, and schizophrenia. Each year, more than 8 million Abilify prescriptions are written.
Lawyers across the country have begun filing lawsuits against Bristol-Myers Squibb on behalf of their clients who developed gambling urges. In October 2016, most Abilify injury lawsuits were consolidated for multidistrict litigation in Florida. The claims being made against the manufacturer include allegations that Bristol-Myers Squibb knew of the risk of compulsive addictions but failed to warn doctors and patients. The lawsuits have included claims for physical, mental, and economic damages.
In August of 2016, after years of being marketed aggressively with no warnings of its side effect of causing compulsive behaviors, Bristol-Myers Squibb made significant changes to Abilify’s package warnings and risk alerts. The company is finally warning doctors that patients can experience intense urges, particularly for gambling, and they may have the inability to control these urges while taking Abilify. The warning also states that because patients may not recognize these behaviors as abnormal, it is important for prescribers to ask patients or their caregivers specifically about the development of new or intense urges while being treated with the drug.
Contact National Drug Injury Attorneys
If you or a loved one is experiencing uncontrollable gambling urges related to treatment with Abilify, give us a call for a free case evaluation so that we can help you get the compensation you deserve. We have successfully handled lawsuits against many drug manufacturers and recovered significant amounts for our clients.
Author: Serena C. Montague
Publication Date: February 15, 2017
Image Source: http://logos.wikia.com/wiki/File:Abilify-logo.jpg